This trial assessed the safety and efficacy of a single dose of lumiracoxib 400 mg compared
to placebo and to a single dose of celecoxib 200mg. It also assessed safety and efficacy of
400mg lumiracoxib administered once a day for 7 days compared to placebo and to 200 mg
celecoxib twice daily.